Recursion Pharmaceuticals (RXRX): Best AI Stocks Under $50 to Buy Right Now

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks under $50 to buy right now. On May 6, Recursion reported significant progress across its AI-driven clinical pipeline for Q1 2026, highlighted by positive early data for its RBM39 degrader, REC-1245. In the Phase 1/2 DAHLIA study, the molecule showed a well-tolerated safety profile with no dose-limiting toxicities and predictable, dose-dependent pharmacokinetics.

Additionally, the company dosed the first patient in its Phase 1 study of REC-4539, a reversible LSD1 inhibitor designed to avoid the platelet toxicity common in similar treatments. These milestones underscore the company’s ability to use its “full stack” OS to rapidly translate biological insights into differentiated clinical candidates.

The company’s advanced programs also reached critical inflection points, particularly REC-4881 for familial adenomatous polyposis/FAP. Following positive Phase 2 data that showed a 53% reduction in polyp burden, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) initiated engagement with the FDA to define a potential registrational pathway, with a formal update expected in H2 2026. The company continues to advance large-scale “maps of biology” with Roche and Genentech, using over 1 trillion internally manufactured neuronal cells to identify novel targets in oncology and immunology.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is a Utah-based clinical-stage biotech company that specializes in the decoding of biology and chemistry. The company develops its solutions by integrating technological advancements in AI and ML to accelerate drug discovery.

While we acknowledge the potential of RXRX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey on Google News.